These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29192343)

  • 1. A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy.
    Rogers RS; Abernathy M; Richardson DD; Rouse JC; Sperry JB; Swann P; Wypych J; Yu C; Zang L; Deshpande R
    AAPS J; 2017 Nov; 20(1):7. PubMed ID: 29192343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
    Jakes C; Millán-Martín S; Carillo S; Scheffler K; Zaborowska I; Bones J
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):1998-2012. PubMed ID: 33513021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis.
    D'Atri V; Fekete S; Beck A; Lauber M; Guillarme D
    Anal Chem; 2017 Feb; 89(3):2086-2092. PubMed ID: 28208257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control.
    Yang F; Zhang J; Buettner A; Vosika E; Sadek M; Hao Z; Reusch D; Koenig M; Chan W; Bathke A; Pallat H; Lundin V; Kepert JF; Bulau P; Deperalta G; Yu C; Beardsley R; Camilli T; Harris R; Stults J
    MAbs; 2023; 15(1):2197668. PubMed ID: 37057828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
    Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y
    MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Attribute Method (MAM) Analytical Workflow for Biotherapeutic Protein Characterization from Process Development to QC.
    Millán-Martín S; Jakes C; Carillo S; Bones J
    Curr Protoc; 2023 Nov; 3(11):e927. PubMed ID: 37929772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.
    Sorensen M; Harmes DC; Stoll DR; Staples GO; Fekete S; Guillarme D; Beck A
    MAbs; 2016 Oct; 8(7):1224-1234. PubMed ID: 27362833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical Performance Evaluation of Identity, Quality-Attribute Monitoring and new Peak Detection in a Platform Multi-Attribute Method Using Lys-C Digestion for Characterization and Quality Control of Therapeutic Monoclonal Antibodies.
    Li X; Pierson NA; Hua X; Patel BA; Olma MH; Strulson CA; Letarte S; Richardson DD
    J Pharm Sci; 2023 Mar; 112(3):691-699. PubMed ID: 36279953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advancements, challenges, and practical considerations in the mass spectrometry-based analytics of protein biotherapeutics: A viewpoint from the biosimilar industry.
    Háda V; Bagdi A; Bihari Z; Timári SB; Fizil Á; Szántay C
    J Pharm Biomed Anal; 2018 Nov; 161():214-238. PubMed ID: 30205300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated mass spectrometry multi-attribute method analyses for process development and characterization of mAbs.
    Song YE; Dubois H; Hoffmann M; D Eri S; Fromentin Y; Wiesner J; Pfenninger A; Clavier S; Pieper A; Duhau L; Roth U
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122540. PubMed ID: 33545564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality Evaluation of Therapeutic Antibodies by Multi-attribute Method].
    Hashii N; Tajiri M; Ishii-Watabe A
    Yakugaku Zasshi; 2022; 142(7):731-744. PubMed ID: 35781502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ID-MAM: A Validated Identity and Multi-Attribute Monitoring Method for Commercial Release and Stability Testing of a Bispecific Antibody.
    Evans AR; Hebert AS; Mulholland J; Lewis MJ; Hu P
    Anal Chem; 2021 Jul; 93(26):9166-9173. PubMed ID: 34161073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-attribute method (MAM) to assess analytical comparability of adalimumab biosimilars.
    Millán-Martín S; Jakes C; Carillo S; Bones J
    J Pharm Biomed Anal; 2023 Sep; 234():115543. PubMed ID: 37385093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
    Pohl T; Gervais A; Dirksen EHC; D'Alessio V; Bechtold-Peters K; Burkitt W; Cao L; Greven S; Lennard A; Li X; Lössner C; Niu B; Reusch D; O'Riordan T; Shearer JW; Spencer D; Xu W; Yi L
    Eur J Pharm Biopharm; 2023 Jul; 188():231-242. PubMed ID: 37146738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing Mass Spectrometry Technology in cGMP Environments.
    Ren D
    Trends Biotechnol; 2020 Oct; 38(10):1051-1053. PubMed ID: 32718778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compliance and regulatory considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory.
    Gervais A; Dirksen EHC; Pohl T; Bechtold-Peters K; Burkitt W; D'Alessio V; Greven S; Lennard A; Li X; Lössner C; Niu B; Reusch D; O'Riordan T; Shearer JW; Spencer D; Xu W; Yi L
    Eur J Pharm Biopharm; 2023 Oct; 191():57-67. PubMed ID: 37582411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and characterization of antibody variants using mass spectrometry-based comparative analysis for biosimilar candidates of monoclonal antibody drugs.
    Li W; Yang B; Zhou D; Xu J; Ke Z; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():57-67. PubMed ID: 27214604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.
    Duivelshof BL; Jiskoot W; Beck A; Veuthey JL; Guillarme D; D'Atri V
    Anal Chim Acta; 2019 Dec; 1089():1-18. PubMed ID: 31627805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive multi-attribute method workflow for biotherapeutic characterization and current good manufacturing practices testing.
    Millán-Martín S; Jakes C; Carillo S; Rogers R; Ren D; Bones J
    Nat Protoc; 2023 Apr; 18(4):1056-1089. PubMed ID: 36526726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics.
    Rogers RS; Nightlinger NS; Livingston B; Campbell P; Bailey R; Balland A
    MAbs; 2015; 7(5):881-90. PubMed ID: 26186204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.